Enhancing Collagen Biosynthesis in Mammalian Cells Through Hypoxia-Mimetic Prolyl Hydroxylase Inhibition
Shahar, B.; Kilimnik, I.; Adriana Lifshits, L.; Netti, F.; Sova, M.; Rosin-Grunewald, D.; Gal, M.; Adler-Abramovich, L.
Show abstract
Collagen, the most abundant protein in the extracellular matrix of mammalian cells, is extensively needed in various biotechnological and therapeutic applications, such as tissue engineering and regeneration, cosmetics, and cultivated meat. Despite the increasing demand for natural collagen from non-animal sources, it is mainly produced from animal connective tissues. Recent research has highlighted that under hypoxia, the activation of the hypoxia-inducible factor (HIF) leads to enhanced collagen type I biosynthesis. However, under normal oxygen conditions, HIF activity is downregulated by the HIF-prolyl hydroxylase (PHD) enzyme. We, therefore, hypothesized that inhibiting PHD could elevate HIF transcriptional activity and enhance collagen biosynthesis under normoxia. Our study demonstrates that inhibiting PHD using exogenous small molecules boosts HIF activity and upregulates the key enzymes, collagen prolyl 4-hydroxylases and lysyl hydroxylases, resulting in up to 29-fold increase in collagen type I in embryonic mouse fibroblast NIH/3T3 cells. These findings suggest that targeting PHD can effectively enhance collagen production in mammalian cells. Therefore, modulating key protein signaling pathways presents a promising strategy for enhancing the production of high-yield natural collagen.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation 95%
- Discovery of A New Class of Integrin Antibodies for Fibrosis 94%
- Selective Impact of ALK and MELK Inhibition on ERα Stability and Cell Proliferation in Cell Lines Representing Distinct Molecular Phenotypes of Breast Cancer 93%
Similar papers in this journal
- Epidermal Growth Factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium 95%
- Small Molecule Screen Identifies Pyrimethamine as an Inhibitor of NRF2-driven Esophageal Hyperplasia 94%
- Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs 93%
Similar papers in this journal
- Mesenchymal-epithelial transition reduces proliferation but increases immune evasion in tumor spheroids 94%
- Versatile roles of Annexin A4 in ccRCC: impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment 93%
- The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis 93%